Peter F. Jowdy

Peter F. Jowdy

Auto-generated profile, based on publicly available information

Peter F. Jowdy

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Journal of Photochemistry and Photobiology
Verified
Journal Article
Open access
ADAnna E. Davis
Anna E. Davis
GKGabrielle E. Kennelley
Gabrielle E. Kennelley
TATatiana Amaye-Obu
Tatiana Amaye-Obu
PJPeter F. Jowdy
Peter F. Jowdy
SGSarah Ghadersohi
Sarah Ghadersohi
WHWendy J Huss
Wendy J Huss
Photosensitivity to structurally diverse drugs is a common but under-reported adverse cutaneous reaction and can be classified as phototoxic or photoallergic. Phototoxic reactions occur when the skin is exposed to sunlight after administering topical or systemic medications that exhibit photosensitizing activity. These reactions depend on the dose of medication, degree of exposure to ultraviolet light, type of ultraviolet light, and sufficient skin distribution volume. Accurate prediction of the incidence and phototoxic response severity is challenging due to a paucity of literature, suggesting that phototoxicity may be more frequent than reported. This paper reports an extensive literature review on phototoxic drugs; the review employed pre-determined search criteria that included meta-analyses, systematic reviews, literature reviews, and case reports freely available in full text. Additional reports were identified from reference sections that contributed to the understanding of phototoxicity. The following drugs and/or drug classes are discussed: amiodarone, voriconazole, chlorpromazine, doxycycline, fluoroquinolones, hydrochlorothiazide, nonsteroidal anti-inflammatory drugs, and vemurafenib. In reviewing phototoxic skin reactions, this review highlights drug molecular structures, their reactive pathways, and, as there is a growing association between photosensitizing drugs and the increasing incidence of skin cancer, the consequential long-term implications of photocarcinogenesis.